In clinical studies, lower mtDNA and TFAM is associated with poorer survival in ovarian cancer [19], oesophageal squamous cell carcinoma [20], colorectal cancer [21] as well as oral squamous cell carcinoma [22]. Here, TFAM is linked to ovarian cancer.